Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

November 01, 1995; Volume 23,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Anderson, C D

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;

B

  1. Baba, T

    1. You have access
      In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;
  2. Barton, H A

    1. You have access
      Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;
  3. Beauchamp, L

    1. You have access
      Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;
  4. Binkley, S N

    1. You have access
      Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;
  5. Boado, R J

    1. You have access
      Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;
  6. Boehlert, C C

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  7. Bonfils, C

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;
  8. Bozler, G

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;
  9. Brashear, W T

    1. You have access
      Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;
  10. Brien, J F

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;
  11. Buhler, D R

    1. You have access
      Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
      W G Chung and D R Buhler
      Drug Metabolism and Disposition November 1995, 23 (11) 1263-1267;
  12. Burke, M D

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;
  13. Busch, U

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

C

  1. Cho, Y B

    1. You have access
      Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;
  2. Choudhuri, S

    1. You have access
      Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
  3. Chung, W G

    1. You have access
      Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
      W G Chung and D R Buhler
      Drug Metabolism and Disposition November 1995, 23 (11) 1263-1267;
  4. Colthup, P V

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;

D

  1. de Miranda, P

    1. You have access
      Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;
  2. Dixon, C M

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  3. Domergue, J

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

E

  1. Ekins, S

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

F

  1. Fujita, S

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

G

  1. Gillet, G

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;

H

  1. Hall, T W

    1. You have access
      Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;
  2. Hawksworth, G M

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;
  3. Heinzel, G

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;
  4. Higuchi, S

    1. You have access
      Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;
  5. Hoshi, H

    1. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

I

  1. Ichimura, F

    1. You have access
      Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

J

  1. Jimmo, S L

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

K

  1. Kang, Y S

    1. You have access
      Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;
  2. Kaschke, S

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;
  3. Kazusaka, A

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;
  4. Kerr, B M

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  5. Kim, D K

    1. You have access
      Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;
  6. Kim, K H

    1. You have access
      Pharmacokinetics, tissue distribution, and excretion of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2-isopropyl-1,3- dioxolane]platinum(II) in dogs.
      Y B Cho, K H Kim and D K Kim
      Drug Metabolism and Disposition November 1995, 23 (11) 1280-1285;
  7. Krasny, H C

    1. You have access
      Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;
  8. Krenitsky, T A

    1. You have access
      Metabolism and pharmacokinetics of a double prodrug of ganciclovir in the rat and monkey.
      H C Krasny, L Beauchamp, T A Krenitsky and P de Miranda
      Drug Metabolism and Disposition November 1995, 23 (11) 1242-1247;
  9. Kumar, G N

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;
  10. Kummer, M

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;

L

  1. Lipscomb, J C

    1. You have access
      Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;

M

  1. Mahle, D A

    1. You have access
      Dichloroacetic acid: metabolism in cytosol.
      J C Lipscomb, D A Mahle, W T Brashear and H A Barton
      Drug Metabolism and Disposition November 1995, 23 (11) 1202-1205;
  2. Marchant, N C

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;
  3. Marks, G S

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;
  4. Masuda, M

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;
  5. Matsubara, T

    1. You have access
      In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;
  6. Matsushita, R

    1. You have access
      Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;
  7. Maurel, P

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;
  8. McLaughlin, B E

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;
  9. McMillan, J M

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;
  10. Murray, G I

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;

N

  1. Nakamura, A

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
  2. Nakashima, E

    1. You have access
      Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;
  3. Nakatsu, K

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

O

  1. Ohshima, T

    1. You have access
      Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;
  2. Ortiz de Montellano, P R

    1. You have access
      The 1994 Bernard B. Brodie Award Lecture. Structure, mechanism, and inhibition of cytochrome P450.
      P R Ortiz de Montellano
      Drug Metabolism and Disposition November 1995, 23 (11) 1181-1187;

P

  1. Pardridge, W M

    1. You have access
      Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;
  2. Park, G R

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  3. Pichard, L

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;
  4. Poklewska-Koziell, M

    1. You have access
      Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
      G S Marks, B E McLaughlin, S L Jimmo, M Poklewska-Koziell, J F Brien and K Nakatsu
      Drug Metabolism and Disposition November 1995, 23 (11) 1248-1252;

S

  1. Schmid, J

    1. You have access
      Pharmacokinetics and metabolic pattern after intravenous infusion and oral administration to healthy subjects.
      J Schmid, U Busch, G Heinzel, G Bozler, S Kaschke and M Kummer
      Drug Metabolism and Disposition November 1995, 23 (11) 1206-1213;
  2. Serabjit-Singh, C J

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  3. Sharer, J E

    1. You have access
      Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;
  4. Shipley, L A

    1. You have access
      Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;
  5. Sugimoto, C

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
  6. Suimamoto, Y

    1. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

T

  1. Tarbit, M H

    1. You have access
      Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans.
      C M Dixon, P V Colthup, C J Serabjit-Singh, B M Kerr, C C Boehlert, G R Park and M H Tarbit
      Drug Metabolism and Disposition November 1995, 23 (11) 1225-1230;
  2. Tasaki, T

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
  3. Taylor, W G

    1. You have access
      Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;
  4. Thénot, J P

    1. You have access
      Oxidative metabolism of zolpidem by human liver cytochrome P450S.
      L Pichard, G Gillet, C Bonfils, J Domergue, J P Thénot and P Maurel
      Drug Metabolism and Disposition November 1995, 23 (11) 1253-1262;
  5. Thomas, P E

    1. You have access
      Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
  6. Touchi, A

    1. You have access
      In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;
  7. Tsuji, A

    1. You have access
      Quantitative relationship between structure and peritoneal membrane transport based on physiological pharmacokinetic concepts for acidic drugs.
      E Nakashima, R Matsushita, T Ohshima, A Tsuji and F Ichimura
      Drug Metabolism and Disposition November 1995, 23 (11) 1220-1224;

U

  1. Usui, T

    1. You have access
      Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;

V

  1. Vandenbranden, M R

    1. You have access
      Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;
  2. Vanderbeck, S M

    1. You have access
      Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
  3. Vedres, D D

    1. You have access
      Metabolites of N-ethylbenzamide, N,N-diethylbenzamide and related compounds detected in rat urine by NMR spectroscopy.
      W G Taylor, T W Hall and D D Vedres
      Drug Metabolism and Disposition November 1995, 23 (11) 1188-1194;

W

  1. Walle, T

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;
  2. Walle, U K

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;
  3. Wang, J

    1. You have access
      Dexamethasone induction of taxol metabolism in the rat.
      C D Anderson, J Wang, G N Kumar, J M McMillan, U K Walle and T Walle
      Drug Metabolism and Disposition November 1995, 23 (11) 1286-1290;
  4. Waskiewicz, M J

    1. You have access
      Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
  5. Watanabe, T

    1. You have access
      Pharmacokinetics of YM175, a new bisphosphonate, in rats and dogs.
      T Usui, T Watanabe and S Higuchi
      Drug Metabolism and Disposition November 1995, 23 (11) 1214-1219;
  6. Williams, J A

    1. You have access
      Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes.
      S Ekins, G I Murray, M D Burke, J A Williams, N C Marchant and G M Hawksworth
      Drug Metabolism and Disposition November 1995, 23 (11) 1274-1279;
  7. Wrighton, S A

    1. You have access
      Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey.
      J E Sharer, L A Shipley, M R Vandenbranden, S N Binkley and S A Wrighton
      Drug Metabolism and Disposition November 1995, 23 (11) 1231-1241;
  8. Wu, D

    1. You have access
      Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.
      R J Boado, Y S Kang, D Wu and W M Pardridge
      Drug Metabolism and Disposition November 1995, 23 (11) 1297-1300;

Y

  1. Yamaguchi, Y

    1. You have access
      In vitro studies to elucidate the metabolic pathway of (+)-S-145, a thromboxane A2 receptor antagonist, in rats. Evidence for two independent pathways in peroxisomal beta-oxidation.
      Y Yamaguchi, T Baba, A Touchi and T Matsubara
      Drug Metabolism and Disposition November 1995, 23 (11) 1195-1201;
  2. Yamamoto, Y

    1. You have access
      Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
      A Nakamura, Y Yamamoto, T Tasaki, C Sugimoto, M Masuda, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1268-1273;
    2. You have access
      Debrisoquine/sparteine-type polymorphic drug metabolism in wild Clethrionomys rufocanus.
      H Hoshi, M Masuda, Y Yamamoto, Y Suimamoto, A Kazusaka and S Fujita
      Drug Metabolism and Disposition November 1995, 23 (11) 1301-1303;

Z

  1. Zhang, X J

    1. You have access
      Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
      M J Waskiewicz, S Choudhuri, S M Vanderbeck, X J Zhang and P E Thomas
      Drug Metabolism and Disposition November 1995, 23 (11) 1291-1296;
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition
Vol. 23, Issue 11
1 Nov 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics